Suzhou Fushilai Pharmaceutical Co. Ltd. Asset Resilience Ratio

Latest as of June 2025: 45.84%

Suzhou Fushilai Pharmaceutical Co. Ltd. asset resilience ratio. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has an Asset Resilience Ratio of 45.84% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 301258 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥977.61 Million

≈ $143.06 Million USD Cash + Short-term Investments

Total Assets

CN¥2.13 Billion

≈ $312.10 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)

Asset resilience ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. This chart shows how Suzhou Fushilai Pharmaceutical Co. Ltd.'s Asset Resilience Ratio has changed over time. Read 301258 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Suzhou Fushilai Pharmaceutical Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 301258 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥977.61 Million	45.84%
Total Liquid Assets	CN¥977.61 Million	45.84%

Asset Resilience Insights

Very High Liquidity: Suzhou Fushilai Pharmaceutical Co. Ltd. maintains exceptional liquid asset reserves at 45.84% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Suzhou Fushilai Pharmaceutical Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Suzhou Fushilai Pharmaceutical Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Suzhou Fushilai Pharmaceutical Co. Ltd. Asset Resilience Ratio by Year (2019–2024)

Suzhou Fushilai Pharmaceutical Co. Ltd. asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Suzhou Fushilai Pharmaceutical Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	53.80%	CN¥1.12 Billion ≈ $164.35 Million	CN¥2.09 Billion ≈ $305.50 Million	+3.25pp
2023-12-31	50.54%	CN¥1.07 Billion ≈ $156.51 Million	CN¥2.12 Billion ≈ $309.65 Million	-4.78pp
2022-12-31	55.33%	CN¥1.16 Billion ≈ $169.89 Million	CN¥2.10 Billion ≈ $307.06 Million	+53.10pp
2021-12-31	2.23%	CN¥21.61 Million ≈ $3.16 Million	CN¥970.31 Million ≈ $141.99 Million	-13.00pp
2020-12-31	15.22%	CN¥120.00 Million ≈ $17.56 Million	CN¥788.25 Million ≈ $115.35 Million	+12.42pp
2019-12-31	2.81%	CN¥21.10 Million ≈ $3.09 Million	CN¥751.44 Million ≈ $109.96 Million	--

pp = percentage points

About Suzhou Fushilai Pharmaceutical Co. Ltd.

SHE:301258 China Biotechnology

Market Cap

$300.48 Million

CN¥2.05 Billion CNY

Market Cap Rank

#14497 Global

#4275 in China

Share Price

CN¥22.40

Change (1 day)

+0.09%

52-Week Range

CN¥21.91 - CN¥37.35

All Time High

CN¥63.49